Serum miR‐22 is a novel prognostic marker for acute myeloid leukemia

BACKGROUND: It has been demonstrated that aberrant expression of serum microRNAs is potential markers for the prognostic prediction of acute myeloid leukemia (AML). However, the clinical significance of serum miR‐22 remained uncovered. In this study, we aimed to explore the potential prognostic valu...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Hong, Zheng, Guodong, Cheng, Shuqin, Xie, Weicheng, Liu, Xiaoshu, Tao, Yuan, Xie, Bixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521259/
https://www.ncbi.nlm.nih.gov/pubmed/32533562
http://dx.doi.org/10.1002/jcla.23370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521259/
https://www.ncbi.nlm.nih.gov/pubmed/32533562
http://dx.doi.org/10.1002/jcla.23370

Ejemplares similares